{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:52:12Z","timestamp":1768251132790,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mycmed.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:42:07Z","timestamp":1532047327000},"page":"414-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department"],"prefix":"10.1016","volume":"28","author":[{"given":"H.F.Z.","family":"Touil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Boucherit-Otmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Boucherit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2018.06.008_bib0160","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s13546-016-1183-6","article-title":"\u00c9pid\u00e9miologie des candidoses invasives en France","volume":"25","author":"Charles","year":"2016","journal-title":"Reanimation"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0165","doi-asserted-by":"crossref","first-page":"11 P","DOI":"10.1155\/2012\/517529","article-title":"Hyphal growth in human fungal pathogens and its role in virulence","volume":"2012","author":"Brand","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bjh.12896","article-title":"Current status of antifungal resistance and its impact on clinical practice","volume":"166","author":"Alcazar-Fuoli","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0175","first-page":"54","article-title":"Candida albicans importance to denture wearers. A literature review","volume":"17","author":"Gleiznys","year":"2015","journal-title":"Stomatologija"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fmed.2018.00028","article-title":"Candida biofilms: threats, challenges, and promising strategies","volume":"5","author":"Cavalheiro","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics4010001","article-title":"The role of antifungals against candida biofilm in catheter-related candidemia","volume":"4","author":"Bouza","year":"2014","journal-title":"J Antibiot"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among candida species: mechanisms and clinical impact","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccm.2017.04.003","article-title":"Overview of treatment approaches for fungal infections","volume":"38","author":"Carmona","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archinte.1987.00370050069012","article-title":"Diagnosis of central venous catheter-related sepsis: critical level of quantitative tip cultures","volume":"147","author":"Brun-Buisson","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0210","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","author":"Clinical Laboratory Standards Institute M27-A3","year":"2008"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0215","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0220","first-page":"1","article-title":"Synergism testing. Broth microdilution checkerboard and broth microdilution methods","volume":"Volume 1","author":"Moody","year":"1991"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0225","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","article-title":"Candidaemia in Europe: epidemiology and resistance","volume":"27","author":"Tortorano","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mycmed.2014.08.005","article-title":"Catheterization and fungal infection risk in the University Hospital of Tlemcen: epidemiology and susceptibility to antifungals","volume":"24","author":"Seghir","year":"2014","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mycmed.2016.02.022","article-title":"Study of strains of Candida spp. Isolated from catheters in UHC of Oran (Algeria): identification and antifungal susceptibility","volume":"26","author":"Bendjelloul","year":"2016","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12941-016-0153-1","article-title":"Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey","volume":"15","author":"Dagi","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0255","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1093\/jac\/dks242","article-title":"Voriconazole inhibits biofilm formation in different species of the genus Candida","volume":"67","author":"Valent\u00edn","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-015-0083-3","article-title":"Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model","volume":"14","author":"El-Azizi","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0265","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0270","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0275","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.mib.2013.03.007","article-title":"Candida albicans biofilms: building a heterogeneous, drug-tolerant environment","volume":"16","author":"Bonhomme","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0280","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/jac\/dkg230","article-title":"Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans","volume":"51","author":"Hossain","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0285","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/AAC.00880-06","article-title":"Caspofungin in combination with amphotericin B against Candida parapsilosis","volume":"51","author":"Barchiesi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11046-011-9459-x","article-title":"Broth microdilution and time\u2013kill testing of caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of candida krusei","volume":"173","author":"Oz","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jac\/dkp429","article-title":"In vitro activity of antifungal combinations against Candida albicans biofilms","volume":"65","author":"Tobudic","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0305","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.48.9.3317-3322.2004","article-title":"In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata","volume":"48","author":"Barchiesi","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2018.06.008_bib0310","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11046-017-0135-7","article-title":"The effectiveness of voriconazole in therapy of Candida glabrata's biofilms oral infections and its influence on the matrix composition and gene expression","volume":"182","author":"Rodrigues","year":"2017","journal-title":"Mycopathologia"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523318300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523318300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:19:35Z","timestamp":1761110375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523318300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1156523318300490"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2018.06.008","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}